Get started
Author

Ken Kurosawa

Observed name: Kurosawa, Ken
ORCID: 0000-0003-3496-883X
Observed ORCID: 0000-0003-3496-883X
OpenAlex ID: A5017220392
Safety, efficacy, and pharmacokinetics of bedaquiline in Japanese patients with pulmonary multidrug-resistant tuberculosis: An interim analysis of an open-label, phase 2 study
2019 · Kazunari Tsuyuguchi, Yuka Sasaki, et al. · Respiratory Investigation · 21
Development of a Pharmacokinetic Model of Transplacental Transfer of Metformin to Predict In Vivo Fetal Exposure
2020 · Ken Kurosawa, Koji Chiba, et al. · Drug Metabolism and Disposition · 16
PDF
In silico modeling for ex vivo placenta perfusion of nicotine
2024 · Harvey Ho, Shengjie Zhang, et al. · Frontiers in Pharmacology · 8
PDF
In Silico Modeling for Ex Vivo Placental Transfer of Morphine
2022 · Harvey Ho, Shengjie Zhang, et al. · The Journal of Clinical Pharmacology · 8
PDF
Population Pharmacokinetic Analysis of Bedaquiline‐Clarithromycin for Dose Selection Against Pulmonary Nontuberculous Mycobacteria Based on a Phase 1, Randomized, Pharmacokinetic Study
2021 · Ken Kurosawa, Stefaan Rossenu, et al. · The Journal of Clinical Pharmacology · 6
PDF
Evaluation of Ethnicity Effect on Intranasal Esketamine Pharmacokinetics by Population Pharmacokinetic Modeling Using Data From a Japanese Phase 2b Study
2022 · Ken Kurosawa, Minaka Shibuya, et al. · Clinical Pharmacology in Drug Development · 5
PDF
Transplacental Pharmacokinetic Model of Digoxin Based on Ex Vivo Human Placental Perfusion Study
2021 · Ken Kurosawa, Saki Noguchi, et al. · Drug Metabolism and Disposition · 3
PDF
Pharmacokinetics, Safety and Antiviral Activity of Rilpivirine in Antiretroviral-naïve Children With HIV ≥6 to <12 Years Old: Week 48 and Final Analysis of Cohort 2 From the Open-label, Phase 2 PAINT Study
2025 · Johan Lombaard, Visal Moolasart, et al. · The Pediatric Infectious Disease Journal · 2
Pharmacokinetics, Safety, Tolerability and Antiviral Activity of Switching to Oral Rilpivirine in Combination With Other Antiretroviral Therapy in Virologically Suppressed Children Living With HIV-1 Infection: Forty-eight-week Results From the Phase 2, Open-label, Single-arm, PICTURE Study
2025 · Johan Lombaard, Francis Ssali, et al. · The Pediatric Infectious Disease Journal
定常状態ヒト胎児曝露量予測のためのex vivoヒト胎盤灌流試験に基づく経胎盤薬物動態モデルの構築 (要約)
2021 · クロサワ, ケン, Kurosawa, Ken, et al. · Institutional Repositories DataBase (IRDB)
PDF
定常状態ヒト胎児曝露量予測のためのex vivoヒト胎盤灌流試験に基づく経胎盤薬物動態モデルの構築 (審査報告)
2021 · クロサワ, ケン, Kurosawa, Ken, et al. · Institutional Repositories DataBase (IRDB)
PDF
定常状態ヒト胎児曝露量予測のためのex vivoヒト胎盤灌流試験に基づく経胎盤薬物動態モデルの構築 (要旨)
2021 · クロサワ, ケン, Kurosawa, Ken, et al. · Institutional Repositories DataBase (IRDB)
PDF
Works count: 12
Citation count: 69
H-index: 5
I10-index: 2
Year
Topic
Type